These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 34748813

  • 1. Effect of polymer source variation on the properties and performance of risperidone microspheres.
    Wan B, Bao Q, Zou Y, Wang Y, Burgess DJ.
    Int J Pharm; 2021 Dec 15; 610():121265. PubMed ID: 34748813
    [Abstract] [Full Text] [Related]

  • 2. Effect of polymer source on in vitro drug release from PLGA microspheres.
    Wan B, Andhariya JV, Bao Q, Wang Y, Zou Y, Burgess DJ.
    Int J Pharm; 2021 Sep 25; 607():120907. PubMed ID: 34332059
    [Abstract] [Full Text] [Related]

  • 3. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature.
    Wan B, Bao Q, Burgess DJ.
    J Control Release; 2022 Jul 25; 347():347-355. PubMed ID: 35569590
    [Abstract] [Full Text] [Related]

  • 4. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres.
    Wan B, Bao Q, Wang R, Burgess DJ.
    Int J Pharm; 2022 Sep 25; 625():122032. PubMed ID: 35878870
    [Abstract] [Full Text] [Related]

  • 5. The effect of PLGA molecular weight differences on risperidone release from microspheres.
    Kohno M, Andhariya JV, Wan B, Bao Q, Rothstein S, Hezel M, Wang Y, Burgess DJ.
    Int J Pharm; 2020 May 30; 582():119339. PubMed ID: 32305366
    [Abstract] [Full Text] [Related]

  • 6. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J, Choi S, Qu W, Wang Y, Burgess DJ.
    J Control Release; 2015 Nov 28; 218():2-12. PubMed ID: 26423236
    [Abstract] [Full Text] [Related]

  • 7. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.
    Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
    J Control Release; 2019 Nov 28; 314():25-37. PubMed ID: 31654687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Influence of PLGA molecular weight distribution on leuprolide release from microspheres.
    Ochi M, Wan B, Bao Q, Burgess DJ.
    Int J Pharm; 2021 Apr 15; 599():120450. PubMed ID: 33675924
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C, Doelker E.
    J Control Release; 1998 Feb 12; 51(2-3):327-41. PubMed ID: 9685930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A reproducible accelerated in vitro release testing method for PLGA microspheres.
    Shen J, Lee K, Choi S, Qu W, Wang Y, Burgess DJ.
    Int J Pharm; 2016 Feb 10; 498(1-2):274-82. PubMed ID: 26705156
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.